on 22 Jun 2021
Last Applicant/ Owned by
London EC4N 6EU
GB
Serial Number
79293085 filed on 16th Jul 2020
Registration Number
6391957 registered on 22nd Jun 2021
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Chemical preparations for pharmaceutical or medical purposes for use in gene therapy for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited met Read More
Pharmaceutical preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Chemical preparations for pharmaceutical or medical purposes for use in gene therapy for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Medicinal preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders
No 79293085
No Service/Collective Mark
No 1056/1/8
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
04th Nov 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
13th Oct 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
13th Oct 2021 | FINAL DISPOSITION PROCESSED |
02th Oct 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
22nd Sep 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
22nd Jun 2021 | REGISTERED-PRINCIPAL REGISTER |
06th Apr 2021 | PUBLISHED FOR OPPOSITION |
06th Apr 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
05th Apr 2021 | NOTIFICATION PROCESSED BY IB |
17th Mar 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |